Investors

 

IPO 2017

Memorandum

Please click here to download our Memorandum (.pdf)

Teaser

Please click here to download our Teaser (.pdf)

Subscription form

Please click here to download our Subscription form (.pdf)

To the news archive

News and Press Releases

2019-08-02

News

2cureX tops off eventful first half of 2019 with addition of expert clinician as Chief Medical Officer (BioStock)

Read it here.

2019-07-30

News

2cureX enrols first patients in pancreatic cancer clinical trials (BioStock)

Read it here.

2019-07-23

Press releases regulatory

2cureX announces that patients are successfully being enrolled in the IndiTreat® pancreatic cancer trial

2cureX AB (“2cureX”, NASDAQ: 2CUREX), a clinical-stage company that has developed the IndiTreat® test allowing individualization of cancer treatment, hereby...

To the news archive

Contact information

Laboratory: 2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail: info@2curex.com

Privacy Policy | Imprint